Revvity Unveils AI Platform for Predictive Molecular Design
Article excerpt
Highlighted: the sentence this signal was extracted from
Revvity unveils AI platform for predictive molecular design. Revvity, Inc. announced the introduction of its forthcoming Signals Xynthetica(TM) Models-as-a Service (MaaS) AI offering within the Revvity Signals platform. The Signals Xynthetica offering will enable AI-augmented molecular and materials design, and brings together advanced in-silico generation, predictive modeling, and experimental validation within a single, governed environment that allows scientific teams to iteratively design, test, and refine candidate molecules with increasing confidence. Across life sciences and materials research, the application of artificial intelligence and machine learning is rapidly shifting discovery from trial-and-error experimentation toward predictive, data driven design. While powerful algorithms and models continue to emerge, their real-world impact is limited without tight integration with high-quality experimental data and the workflows scientists already use. The Signals Xynthetica offering is intended to address this gap by embedding models directly into the scientific context, connecting AI predictions with real wet-lab outcomes to drive continuous learning and improvement. The Signals Xynthetica platform will support a wide range of in-silico design approaches, including de novo generation, property prediction, and multi-objective optimization. Delivered as an AI MaaS...
Keep reading with a free account
The rest of this article, and every signal for Revvity, is in your free account.